EP 0865298 A1 19980923 - DRUG THERAPY
Title (en)
DRUG THERAPY
Title (de)
ARZNEIMITTEL THERAPIE
Title (fr)
TRAITEMENT MEDICAMENTEUX
Publication
Application
Priority
- GB 9603000 W 19961206
- GB 9524942 A 19951206
Abstract (en)
[origin: WO9720580A1] A therapeutic system comprising: (a) a compound comprising a target cell-specific portion and a portion capable of converting a substance into another substance; and (b) a molecule capable of substantially inhibiting the conversion of said substance, or a precursor of said molecule. In one particularly preferred embodiment said other substance is cytotoxic and said substance is substantially non-cytotoxic, the system further comprising said substance. In a second particularly preferred embodiment said substance, in its native state, is able to inhibit the effect of a cytotoxic agent and said other substance has less effect against said cytotoxic agent, the system further comprising (a) a cytotoxic agent and (b) said substance.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/505 (2006.01); A61K 38/43 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 47/48 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07C 333/04 (2006.01); C07D 213/72 (2006.01); C07D 239/38 (2006.01)
CPC (source: EP)
A61K 47/6899 (2017.07); A61P 35/00 (2017.12); A61P 43/00 (2017.12); B82Y 5/00 (2013.01); C07C 333/04 (2013.01); C07D 213/72 (2013.01); C07D 239/38 (2013.01)
Citation (search report)
See references of WO 9720580A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9720580 A1 19970612; CA 2239203 A1 19970612; EP 0865298 A1 19980923; GB 9524942 D0 19960207; JP 2000502071 A 20000222
DOCDB simple family (application)
GB 9603000 W 19961206; CA 2239203 A 19961206; EP 96940685 A 19961206; GB 9524942 A 19951206; JP 52108297 A 19961206